Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
| Image |  |
|---|---|
| Description | scholarly article by Farhad Ravandi et al published November 2018 in Haematologica |
| Author/s |
author: Elias Jabbour Gary Acton Stephen A. Strickland Angelo Michele Carella Jorge Eduardo Cortes Norbert Vey Hagop Kantarjian Arnaud Pigneux Heinz-August Horst Virginia M Klimek Hamid Sayar Jeffrey E Lancet Gary J Schiller Farhad Ravandi |
| Publication date | November 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |